Screening for lymphatic disorders involving the FLT4 receptor tyrosine kinase (VEGFR-3)
US6764820B2 · kind B2 · utility
4Cited by
12References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 16, 1999 |
| Grant date | Jul 20, 2004 |
| Priority date | — |
| Expiry date | Aug 16, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/156
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides materials and methods for screening for and treating hereditary lymphedema in human subjects.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.